Abstract
This article highlights recent advances in the discovery of new positive allosteric modulators of the AMPA receptor, excluding compounds of thiadiazine chemotype, most of which were developed by Servier and the University of Liege. The field of AMPA receptor modulators continues to be a fertile area for the discovery of new potential therapeutic agents, and recent years have seen a marked diversification in the range of chemotypes prepared. An overview is also given of the recent key new biological data.
Keywords: AMPA receptor, AMPA positive modulator, thiadiazine chemotype, glutamatergic neurotransmitter system, neurodegenerative diseases, schizophrenia,Alzheimer's disease, Parkinson's disease, postsynaptic membrane, tetrameric complex, AMPAR complex, synaptic plasticity, glutamate bound dimer, benzothiadiazines, cornichon proteins, deactivation kinetics, cystine-knot AMPAR, cognitive performance, preclinical behavioural testing, chemotypes, trifluoromethylpyrazole, D-amphetamine-stimulated locomotion, Phenethyl Sulfonamide Series, aromatic thiophene linker, cell voltage-clamp electrophysiology, FLIPR-based assays, Cyclopropane Derivatives, FLUO-4, HEK293, indane core structure, Pyrrole/Thiophene Acid Series, Iminothiazole, Trifluoromethylpyrazole Series
Current Medicinal Chemistry
Title: Recent Advances in the Discovery of Selective AMPA Receptor Positive Allosteric Modulators
Volume: 17 Issue: 30
Author(s): Simon E. Ward and Mark Harries
Affiliation:
Keywords: AMPA receptor, AMPA positive modulator, thiadiazine chemotype, glutamatergic neurotransmitter system, neurodegenerative diseases, schizophrenia,Alzheimer's disease, Parkinson's disease, postsynaptic membrane, tetrameric complex, AMPAR complex, synaptic plasticity, glutamate bound dimer, benzothiadiazines, cornichon proteins, deactivation kinetics, cystine-knot AMPAR, cognitive performance, preclinical behavioural testing, chemotypes, trifluoromethylpyrazole, D-amphetamine-stimulated locomotion, Phenethyl Sulfonamide Series, aromatic thiophene linker, cell voltage-clamp electrophysiology, FLIPR-based assays, Cyclopropane Derivatives, FLUO-4, HEK293, indane core structure, Pyrrole/Thiophene Acid Series, Iminothiazole, Trifluoromethylpyrazole Series
Abstract: This article highlights recent advances in the discovery of new positive allosteric modulators of the AMPA receptor, excluding compounds of thiadiazine chemotype, most of which were developed by Servier and the University of Liege. The field of AMPA receptor modulators continues to be a fertile area for the discovery of new potential therapeutic agents, and recent years have seen a marked diversification in the range of chemotypes prepared. An overview is also given of the recent key new biological data.
Export Options
About this article
Cite this article as:
E. Ward Simon and Harries Mark, Recent Advances in the Discovery of Selective AMPA Receptor Positive Allosteric Modulators, Current Medicinal Chemistry 2010; 17 (30) . https://dx.doi.org/10.2174/092986710792927840
DOI https://dx.doi.org/10.2174/092986710792927840 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Scenario of 1,4-Diazepines as Potent Biomolecules-A Mini Review
Mini-Reviews in Medicinal Chemistry Tuberculosis Therapeutics: Past Achievements, Present Road-Blocks and Future Perspectives
Letters in Drug Design & Discovery Ivabradine: A Current Overview
Current Clinical Pharmacology Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Electrochemical Biosensor for the Detection of Glycated Albumin
Current Alzheimer Research Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls
Current Pharmaceutical Design Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
CNS & Neurological Disorders - Drug Targets Aspirin Resistance in Cardiovascular Disease: Pathogenesis, Diagnosis and Clinical Impact
Current Pharmaceutical Design Editorial (Hot Topic: New Insight into the RAMP-based Family B GPCRs and their Peptide Ligands)
Current Protein & Peptide Science Changes in Rat 50-kHz Ultrasonic Vocalizations During Dopamine Denervation and Aging: Relevance to Neurodegeneration
Current Neuropharmacology Fragile X Syndrome
Current Genomics Effects of an Acute Treatment with L-Thyroxine on Memory, Habituation, Danger Avoidance, and on Na+, K+-ATPase activity in Rat Brain
Current Neurovascular Research Pharmacological Approaches in the Treatment of Atrial Fibrillation
Current Medicinal Chemistry Microarrays and Colon Cancer in the Road for Translational Medicine
Current Bioinformatics Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Medicinal Chemistry Approaches of Controlling Gastrointestinal Side Effects of Non-Steroidal Anti-Inflammatory Drugs. Endogenous Protective Mechanisms and Drug Design
Medicinal Chemistry Sensitivity of Different MRI-Techniques to Assess Gray Matter Atrophy Patterns in Alzheimer’s Disease is Region-Specific
Current Alzheimer Research Research Progress and Discussion of Waxy Crude Pour Point Depressants: A Mini Review
Recent Innovations in Chemical Engineering Assessing Coronary Blood Flow Physiology in the Cardiac Catheterisation Laboratory
Current Cardiology Reviews The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence
Current Drug Targets